‘This really won’t be the last epidemic’

A phone call early in 2020 marked the start of a taxing year for Andrea Pruijssers in Nashville, Tennessee. She and her colleagues had to pull out all the stops to get blood analyses done for the first test phase of the Moderna vaccine. ‘We saw in May that the vaccine did activate antibodies that potently neutralized the coronavirus. Fantastic!’